What is the current Blood Product market size?

The Blood Product market size is approximately USD 43.8 billion as of 2023.

What is the expected growth forecast for the Blood Product market?

The market is expected to grow at a CAGR of 4.8% from 2023 to 2028.

What are the key drivers of the Blood Product market?

Increasing demand for blood components and growing prevalence of blood disorders drive the market.

What are the major challenges facing the Blood Product market?

Stringent regulatory requirements and high production costs are significant challenges.

Which regions are the leaders in the Blood Product market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Blood Product market?

Top companies include Grifols, Baxter, and Octapharma, which dominate the global market.

What are the future opportunities in the Blood Product market?

Emerging markets and increasing adoption of blood products in developing countries offer growth opportunities.

How does technology impact the Blood Product market?

Advances in technology improve blood component separation and storage, enhancing the future outlook.

What is the current regulatory landscape for the Blood Product market?

Regulatory bodies like FDA and EMA oversee the market, ensuring safety and efficacy of blood products.

What is the expected future outlook for the Blood Product market?

The market is expected to witness significant growth due to increasing demand for blood products.

Blood Product Value Chain Analysis & Forecast Outlook 2033

Blood Product by Application (Hospital, Retail Pharmacy, Other), by Types (Albumin, Immunoglobulin, Clotting Factor, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 124

Forecast Period: 2026 - 2033

Market Size: $12345 million

CAGR: 0.065%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Blood Product Market Overview

The Blood Product market refers to the industry responsible for developing, manufacturing, and distributing various blood-derived products used in medical treatments. The Blood Product market size is estimated to be around $43.8 billion in 2025, with a growth outlook that is expected to drive the industry forward. As the market forecast suggests, the industry is poised for significant expansion, with a projected compound annual growth rate (CAGR) of 5.5% from 2026 to 2033. The scope of the Blood Product market encompasses a range of products, including whole blood, red blood cells, platelets, and plasma, which are used to treat various medical conditions, such as anemia, bleeding disorders, and immune system disorders.

Loading chart…

The Blood Product market is driven by several key forces, including technology shifts, such as the development of new blood screening tests, regulations, such as those related to blood safety and quality, and consumer behavior, such as the increasing demand for blood products in emerging markets. The largest region in the Blood Product market is currently North America, while the fastest-growing region is Asia-Pacific, driven by the increasing demand for blood products in countries such as China and India. The industry is expected to continue to evolve in response to these and other factors, driving industry expansion and market growth.

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.41 billion
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Takeda; CSL; Grifols; Octapharma; Kedrion; LFB Group; Biotest; BPL; Shanghai RAAS; China Biologic Products; Hualan Biological Engineering Inc.; Beijing Tiantan Biological Products Corp; Pacific Shuanglin; Boya Bio-Pharmaceutical; Paisi Feike Biology Pharmacy Co.,Ltd.; Xinjiang Deyuan Bioengineering; Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.; Shenzhen Weiguang; Shanxi Kangbao; Nanyue Biopharming Corporation Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Product market is witnessing significant growth, driven by various factors. The following sections outline the key dynamics influencing the Blood Product market size and growth forecast.

Growth Drivers2 items

Advances in technology, such as pathogen reduction and viral inactivation, are enhancing the safety and efficacy of blood products, thereby driving demand and contributing to the growth forecast of the Blood Product market.

Increasing prevalence of bleeding disorders, such as hemophilia, is fueling the need for blood products, resulting in an expansion of the Blood Product market size.

Restraints2 items

Stringent regulations and standards for blood product manufacturing and distribution are limiting the entry of new players in the Blood Product market, which may impact the growth forecast.

High costs associated with blood screening and testing are creating a barrier to entry for smaller manufacturers, affecting the overall Blood Product market size.

Opportunities2 items

Emerging markets, such as Asia-Pacific, offer significant opportunities for growth due to increasing demand for blood products, driven by a rising patient population and improving healthcare infrastructure, contributing to the expansion of the Blood Product market size.

The development of novel blood products, such as recombinant clotting factors, is expected to drive growth in the Blood Product market, influencing the overall growth forecast.

Challenges2 items

Ensuring a stable blood supply chain is a significant challenge, as it requires careful planning and management to maintain adequate inventory levels and prevent shortages, which can impact the Blood Product market size and growth forecast.

Managing pricing pressures and maintaining profitability is a challenge for manufacturers, as the Blood Product market is subject to fluctuating demand and intense competition, affecting the overall growth forecast of the Blood Product market.

Market Segmentation

Loading chart…

The Application segment of the Blood Product market is a crucial aspect of Blood Product segmentation. This market can be divided into various applications, including surgical procedures, trauma cases, and therapeutic treatments. Each application contributes to the overall Blood Product market size, with surgical procedures accounting for a significant share. The application segment is further sub-divided into categories such as plasma fractionation, recombinant coagulation factors, and immunoglobulins, among others.

The Types segment of the Blood Product market is another essential aspect of market taxonomy. This segment can be categorized into whole blood, red blood cells, platelets, plasma, and cryoprecipitate, among others. Each type has its own set of subtypes, such as leukoreduced red blood cells and irradiated platelets. The types segment contributes significantly to the overall Blood Product market size, with whole blood and red blood cells being the most commonly used products. Understanding the different types and subtypes of blood products is critical for Blood Product segmentation and market analysis.

Blood Product Segmentation Breakdown9 items

Application

Hospital

Retail Pharmacy

Other

Types

Albumin

Immunoglobulin

Clotting Factor

Others

Regional Insights

Loading chart…

The Blood Product market growth is expected to vary across regions, driven by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. The largest region, North America, accounts for approximately 35% of the market share, driven by key drivers such as increased demand for blood products, advancements in technology, and established healthcare infrastructure.

The fastest-growing region, Asia Pacific, is expected to drive regional forecast with a growth rate driven by key drivers such as growing demand for blood products, increasing investments in healthcare infrastructure, and government initiatives to promote blood donation. Europe accounts for approximately 25% of the market share, driven by key drivers such as established blood banking systems, strict regulations, and high awareness about blood donation. Latin America and Middle East & Africa account for approximately 15% and 10% of the market share, respectively, driven by key drivers such as growing healthcare expenditure, increasing awareness about blood donation, and government initiatives to improve healthcare infrastructure.

Regional Key Drivers5 items

North America: increased demand for blood products, advancements in technology, established healthcare infrastructure

Europe: established blood banking systems, strict regulations, high awareness about blood donation

Asia Pacific: growing demand for blood products, increasing investments in healthcare infrastructure, government initiatives to promote blood donation

Latin America: growing healthcare expenditure, increasing awareness about blood donation, government initiatives to improve healthcare infrastructure

Middle East & Africa: growing healthcare expenditure, increasing awareness about blood donation, government initiatives to improve healthcare infrastructure

Competitive Landscape

The Blood Product market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Blood Product competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves. Key competitive levers include product innovation, distribution networks, and regulatory compliance.

Companies in the Blood Product market are adopting strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. Common challenges include margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are employing various strategic focuses:

Takeda: regional expansion

CSL: innovation pipeline

Grifols: vertical integration

Octapharma: premium pricing

Kedrion: OEM tie-ups

LFB Group: local manufacturing

Key Blood Product Companies20 items

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co.,Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

Market Ecosystem

The Blood Product ecosystem encompasses a complex network of stakeholders, spanning upstream, midstream, and downstream segments. It involves the convergence of technology providers, suppliers, integrators, channels, and end users, all of which contribute to the creation and capture of value. The ecosystem boundaries are defined by the interactions among these stakeholders, from the sourcing of raw materials to the delivery of blood products to end users, highlighting the importance of a thorough value chain analysis.

Raw material suppliers — providing plasma and other essential components

OEMs / manufacturers — producing blood products

Technology providers — developing testing and processing technologies

Distributors / channel partners — facilitating product delivery

Service providers / after-sales — offering support and maintenance services

End users / buyers — hospitals, clinics, and research institutions

Regulators/standards bodies — establishing safety and quality standards

The flow of value within the Blood Product ecosystem is influenced by various control points, including regulatory approvals, standards compliance, and the availability of raw materials. Dependency risks arise from input constraints, such as plasma shortages, and the need for approvals from regulatory bodies. Switching costs and partnerships between stakeholders can also impact the ecosystem, while interoperability requirements may vary by region, affecting the overall dynamics of the Blood Product ecosystem.

Recent Industry Insights

The Blood Product industry has witnessed significant developments over the last 12-18 months, shaping Blood Product industry trends. Recent partnerships have focused on enhancing product portfolios and expanding global reach. Notable mergers and acquisitions have led to consolidation, while product launches have centered on innovative technologies and treatments. Regulatory changes have emphasized safety and efficacy, prompting companies to adapt their strategies. A shift in consumer trends towards personalized medicine has driven investment in research and development. Furthermore, funding rounds and expansions have supported the growth of emerging players, underscoring the industry's potential for innovation and growth.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Blood Product market outlook. The market attractiveness is moderate, driven by increasing demand for blood products and advancements in medical technology. The competitive intensity is high, with key players competing for market share. The long-term outlook is positive, with opportunities for growth in emerging markets and innovation in blood product development.

The innovation landscape is evolving, with a focus on improving blood product safety and efficacy. However, the demand–supply balance is a concern, with potential shortages in certain regions. Key risk factors include regulatory changes, supply chain disruptions, and fluctuations in demand. Overall, the Blood Product market outlook is promising, with opportunities for growth and innovation, but also requires careful management of risks and challenges.

11 items

1. Executive Summary

2. Blood Product Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Blood Product Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Blood Product Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Retail Pharmacy

6.1.3. Other

6.2. Global Blood Product Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Albumin

6.2.2. Immunoglobulin

6.2.3. Clotting Factor

6.2.4. Others

6.3. Global Blood Product Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Blood Product Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Blood Product Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Blood Product Market Competition by Key Manufacturers

8.1. Global Blood Product Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Blood Product: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Takeda

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CSL

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Grifols

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Octapharma

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Kedrion

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. LFB Group

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biotest

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BPL

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shanghai RAAS

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. China Biologic Products

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hualan Biological Engineering Inc.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Beijing Tiantan Biological Products Corp

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Pacific Shuanglin

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Boya Bio-Pharmaceutical

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Paisi Feike Biology Pharmacy Co.,Ltd.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Xinjiang Deyuan Bioengineering

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Shenzhen Weiguang

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Shanxi Kangbao

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Nanyue Biopharming Corporation Ltd

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Blood Product Market

Figure 4: Global Blood Product Market: Drivers

Figure 5: Global Blood Product Market: Challenges

Figure 6: Global Blood Product Market: Trends

Figure 7: Global Blood Product Market: Opportunity

Figure 8: Global Blood Product Market: Restraint

Figure 9: Global Blood Product Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Blood Product Market Value (USD Million) By Region

Figure 15: Global Blood Product Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Blood Product Market Value (USD Million) By Region

Figure 23: Global Blood Product Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Blood Product Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Blood Product Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Blood Product Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Blood Product Market Value (USD Million) By Region

Table 10: Global Blood Product Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Blood Product Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Blood Product Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Blood Product Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Takeda Basic Information And Sales Area

Table 31: Takeda. Products Portfolio

Table 32: CSL Basic Information And Sales Area

Table 33: CSL. Products Portfolio

Table 34: Grifols Basic Information And Sales Area

Table 35: Grifols. Products Portfolio

Table 36: Octapharma Basic Information And Sales Area

Table 37: Octapharma. Products Portfolio

Table 38: Kedrion Basic Information And Sales Area

Table 39: Kedrion. Products Portfolio

Table 40: LFB Group Basic Information And Sales Area

Table 41: LFB Group. Products Portfolio

Table 42: Biotest Basic Information And Sales Area

Table 43: Biotest. Products Portfolio

Table 44: BPL Basic Information And Sales Area

Table 45: BPL. Products Portfolio

Table 46: Shanghai RAAS Basic Information And Sales Area

Table 47: Shanghai RAAS. Products Portfolio

Table 48: China Biologic Products Basic Information And Sales Area

Table 49: China Biologic Products. Products Portfolio

Table 50: Hualan Biological Engineering Inc. Basic Information And Sales Area

Table 51: Hualan Biological Engineering Inc.. Products Portfolio

Table 52: Beijing Tiantan Biological Products Corp Basic Information And Sales Area

Table 53: Beijing Tiantan Biological Products Corp. Products Portfolio

Table 54: Pacific Shuanglin Basic Information And Sales Area

Table 55: Pacific Shuanglin. Products Portfolio

Table 56: Boya Bio-Pharmaceutical Basic Information And Sales Area

Table 57: Boya Bio-Pharmaceutical. Products Portfolio

Table 58: Paisi Feike Biology Pharmacy Co.,Ltd. Basic Information And Sales Area

Table 59: Paisi Feike Biology Pharmacy Co.,Ltd.. Products Portfolio

Table 60: Xinjiang Deyuan Bioengineering Basic Information And Sales Area

Table 61: Xinjiang Deyuan Bioengineering. Products Portfolio

Table 62: Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 63: Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 64: Shenzhen Weiguang Basic Information And Sales Area

Table 65: Shenzhen Weiguang. Products Portfolio

Table 66: Shanxi Kangbao Basic Information And Sales Area

Table 67: Shanxi Kangbao. Products Portfolio

Table 68: Nanyue Biopharming Corporation Ltd Basic Information And Sales Area

Table 69: Nanyue Biopharming Corporation Ltd. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Blood Product Market Value (USD Million) By Region

Table 75: Global Blood Product Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Blood Product Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.35 billion
Revenue forecast in 2033	12.41 billion
Growth rate	CAGR of 0.065% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Takeda; CSL; Grifols; Octapharma; Kedrion; LFB Group; Biotest; BPL; Shanghai RAAS; China Biologic Products; Hualan Biological Engineering Inc.; Beijing Tiantan Biological Products Corp; Pacific Shuanglin; Boya Bio-Pharmaceutical; Paisi Feike Biology Pharmacy Co.,Ltd.; Xinjiang Deyuan Bioengineering; Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.; Shenzhen Weiguang; Shanxi Kangbao; Nanyue Biopharming Corporation Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Blood Product market is witnessing significant growth, driven by various factors. The following sections outline the key dynamics influencing the Blood Product market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of bleeding disorders, such as hemophilia, is fueling the need for blood products, resulting in an expansion of the Blood Product market size.

Restraints2 items

Stringent regulations and standards for blood product manufacturing and distribution are limiting the entry of new players in the Blood Product market, which may impact the growth forecast.

High costs associated with blood screening and testing are creating a barrier to entry for smaller manufacturers, affecting the overall Blood Product market size.

Opportunities2 items

The development of novel blood products, such as recombinant clotting factors, is expected to drive growth in the Blood Product market, influencing the overall growth forecast.

Challenges2 items

Market Segmentation

Loading chart…

Blood Product Segmentation Breakdown9 items

Application

Hospital

Retail Pharmacy

Other

Types

Albumin

Immunoglobulin

Clotting Factor

Others

Regional Insights

Loading chart…

Regional Key Drivers5 items

North America: increased demand for blood products, advancements in technology, established healthcare infrastructure

Europe: established blood banking systems, strict regulations, high awareness about blood donation

Asia Pacific: growing demand for blood products, increasing investments in healthcare infrastructure, government initiatives to promote blood donation

Latin America: growing healthcare expenditure, increasing awareness about blood donation, government initiatives to improve healthcare infrastructure

Middle East & Africa: growing healthcare expenditure, increasing awareness about blood donation, government initiatives to improve healthcare infrastructure

Competitive Landscape

Takeda: regional expansion

CSL: innovation pipeline

Grifols: vertical integration

Octapharma: premium pricing

Kedrion: OEM tie-ups

LFB Group: local manufacturing

Key Blood Product Companies20 items

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co.,Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co.,Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

Market Ecosystem

Raw material suppliers — providing plasma and other essential components

OEMs / manufacturers — producing blood products

Technology providers — developing testing and processing technologies

Distributors / channel partners — facilitating product delivery

Service providers / after-sales — offering support and maintenance services

End users / buyers — hospitals, clinics, and research institutions

Regulators/standards bodies — establishing safety and quality standards

Recent Industry Insights

Analyst Overview

Table of Contents